Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition
Is glutathione the master antioxidant
Administering ipamorelin alone in the morning and the blend at night
doi: 10.1016/j.brs.2023.03.003 112
Amazing Formulas L-Glutathione is an anti-inflammatory supplement that is the most bio-available form of glutathione, allowing it to absorb
Researchers have been working on studies to see if glutathione can help with the following: Restoring gut enzymes Managing asthma and other respiratory disorders Reducing the effects of autism Treating skin conditions, such as acne Treating rheumatoid arthritis Reducing the damage caused by drugs and alcohol Treating schizophrenia Treating sleep problems, such as sleep apnea Preventing addiction Managing ADHD Preventing heart disease Reducing the effects of type II diabetes Preventing kidney disease To be clear, these benefits are yet to be conclusively proven
